ArticleCureus2026
Maternal and Fetal Outcomes in Early-Onset vs. Late-Onset Preeclampsia: A Retrospective Study at a Tertiary Care Institute in India.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Late-Onset Preeclampsia Is Linked to Extensive Remodeling of the Placental Extracellular Matrix.Medical sciences (Basel, Switzerland) · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Preeclampsia is a hypertensive disorder of pregnancy associated with significant maternal and perinatal morbidity and mortality. Distinguishing between early- and late-onset preeclampsia is crucial due to differences in pathophysiology, severity, and outcomes. This study aimed to evaluate and contrast clinical characteristics, complications, and outcomes between the two types. Aim & objective The aim of the study is to compare the maternal and fetal outcomes in pregnancies complicated by early-onset preeclampsia (before 34 weeks) versus late-onset preeclampsia (34 weeks or later) and identify specific clinical risks and prognostic implications associated with the timing of disease onset. Materials & methods A hospital-based retrospective observational study was conducted at Smt. Kashibai Navale Medical College and General Hospital, Pune, from November 2022 to October 2024. A total of 88 pregnant women diagnosed with preeclampsia were categorized into early-onset (<34 weeks) and late-onset (≥34 weeks) groups. Clinical data were extracted from medical records and analyzed using chi-square and Fisher's exact tests to assess associations between disease onset and maternal/neonatal outcomes. Results Among the 88 cases, early-onset and late-onset preeclampsia were nearly evenly distributed (48.9% vs. 51.1%). Severe preeclampsia was significantly more frequent in the early-onset group (93.0% vs. 62.2%, p=0.001). Early-onset preeclampsia was strongly associated with the cases who underwent IVF (in vitro fertilization) treatment (p=0.001). Early-onset cases had significantly higher rates of preterm delivery (<34 weeks: 76.7%), extremely low birth weight (<1.5 kg: 65.1%), intrauterine death (20.9%, p=0.002), NICU (Neonatal Intensive Care Unit) admissions (p<0.001), and low APGAR scores (p<0.001). Maternal complications were more frequent in early-onset cases, although the difference was not statistically significant. Discussion The study affirms that early-onset preeclampsia is associated with great severity disease and significantly poorer neonatal outcomes, especially in terms of prematurity, fetal growth restriction, and neonatal morbidity. IVF emerged as a notable risk factor for early-onset pre-eclampsia. Despite higher complication rates, maternal mortality was zero in this cohort. Conclusion Early-onset preeclampsia poses greater risks to both mother and fetus than late-onset disease. Identifying high-risk pregnancies, especially IVF conceptions, and implementing timely interventions are essential to improving outcomes. Enhanced surveillance and preparedness of neonatal intensive care are particularly critical in early-onset cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.